OP
VKTX icon

ORG Partners’s Viking Therapeutics VKTX Stock Holding History

ORG Partners’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.03K Buy
143
+33
+30% +$1.17K ﹤0.01% 1220
2025
Q3 		$2.89K Buy
110
+60
+120% +$1.79K ﹤0.01% 1249
2025
Q2 		$1.33K Hold
50
– – ﹤0.01% 1295
2025
Q1 		$1.2K Sell
50
-150
-75% -$4.74K ﹤0.01% 1147
2024
Q4 		$8.05K Buy
+200
New +$11.4K ﹤0.01% 939
2024
Q3 		– Sell
-4,429
Closed -$245K – 1384
2024
Q2 		$245K Buy
+4,429
New +$290K 0.03% 384

Other funds holding VKTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return